1537 related articles for article (PubMed ID: 18199861)
21. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
22. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis.
Gurrin LC; Osborne NJ; Constantine CC; McLaren CE; English DR; Gertig DM; Delatycki MB; Southey MC; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ;
Gastroenterology; 2008 Dec; 135(6):1945-52. PubMed ID: 18848943
[TBL] [Abstract][Full Text] [Related]
23. HFE genotype in patients with hemochromatosis and other liver diseases.
Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
[TBL] [Abstract][Full Text] [Related]
24. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
[TBL] [Abstract][Full Text] [Related]
25. Hereditary hemochromatosis in north-eastern Romania.
Voicu PM; Cojocariu C; Petrescu-Dănilă E; Stanciu C; Covic M; Rusu M; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):982-7. PubMed ID: 21495455
[TBL] [Abstract][Full Text] [Related]
26. Screening for iron overload in the Turkish population.
Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
[TBL] [Abstract][Full Text] [Related]
27. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
[TBL] [Abstract][Full Text] [Related]
28. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening.
Gleeson F; Ryan E; Barrett S; Crowe J
Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):859-63. PubMed ID: 15316409
[TBL] [Abstract][Full Text] [Related]
29. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort.
Pilling LC; Atkins JL; Melzer D
Hepatology; 2022 Dec; 76(6):1735-1745. PubMed ID: 35567766
[TBL] [Abstract][Full Text] [Related]
30. HFE mutations, iron deficiency and overload in 10,500 blood donors.
Jackson HA; Carter K; Darke C; Guttridge MG; Ravine D; Hutton RD; Napier JA; Worwood M
Br J Haematol; 2001 Aug; 114(2):474-84. PubMed ID: 11529872
[TBL] [Abstract][Full Text] [Related]
31. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
32. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
33. HFE based re-evaluation of heterozygous hemochromatosis.
Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
Byrnes V; Ryan E; O'Keane C; Crowe J
Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
[TBL] [Abstract][Full Text] [Related]
35. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
[TBL] [Abstract][Full Text] [Related]
36. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.
Aguilar-Martinez P; Grandchamp B; Cunat S; Cadet E; Blanc F; Nourrit M; Lassoued K; Schved JF; Rochette J
Haematologica; 2011 Apr; 96(4):507-14. PubMed ID: 21228038
[TBL] [Abstract][Full Text] [Related]
37. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria.
Brissot P; Moirand R; Jouanolle AM; Guyader D; Le Gall JY; Deugnier Y; David V
J Hepatol; 1999 Apr; 30(4):588-93. PubMed ID: 10207799
[TBL] [Abstract][Full Text] [Related]
38. CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.
Pelucchi S; Mariani R; Calza S; Fracanzani AL; Modignani GL; Bertola F; Busti F; Trombini P; Fraquelli M; Forni GL; Girelli D; Fargion S; Specchia C; Piperno A
Haematologica; 2012 Dec; 97(12):1818-25. PubMed ID: 22773607
[TBL] [Abstract][Full Text] [Related]
39. Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients.
McCune CA; Ravine D; Carter K; Jackson HA; Hutton D; Hedderich J; Krawczak M; Worwood M
Gut; 2006 Apr; 55(4):554-62. PubMed ID: 16174659
[TBL] [Abstract][Full Text] [Related]
40. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria.
Adams PC; Chakrabarti S
Gastroenterology; 1998 Feb; 114(2):319-23. PubMed ID: 9453492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
